Qiong Wu
UCL Institute of Child Health
7 Papers
12 Citations
Qiong Wu is an academic researcher from UCL Institute of Child Health. The author has contributed to research in topics: T cell & FOXP3. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Qiong Wu include Imperial College London & University College London.
Chat about Author
Papers
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines
TL;DR: It is demonstrated that CD161+FoxP3+ T cells are a novel Treg subset, found in health and disease, which display high proinflammatory potential but also exhibit hallmark Treg characteristics.
170
Immunological characteristics and T‐cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T‐cell‐depleted autologous stem cell transplantation
Qiong Wu,Anne M. Pesenacker,Alka Stansfield,Douglas King,Dawn Barge,Helen E. Foster,Mario Abinun,Mario Abinun,Lucy R. Wedderburn,Lucy R. Wedderburn +9 more
TL;DR: It is suggested that a chimeric TCR repertoire, comprising T‐cell clones developed before and after transplant, can be associated with clinical remission from severe arthritis.
26
Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
Qiong Wu,Hema Chaplin,Nicola Ambrose,Debajit Sen,M Leandro,Charlotte Wing,Nicola Daly,Kate Webb,Corinne Fisher,Linda Suffield,Francesca Josephs,Clarissa Pilkington,Despina Eleftheriou,Muthana Al-Obaidi,Sandrine Compeyrot-Lacassagne,Lucy R. Wedderburn,Yiannis Ioannou +16 more
TL;DR: This study compared DAS28 with JADAS-10 in adolescents and adults with polyJIA and found that the former is more accurate than the latter in terms of assessing the pattern of joint involvement.
15
Juvenile dermatomyositis: Latest advances
TL;DR: Registries and biobanks for juvenile dermatomyositis (JDM) have generated statistical power to help understand pathogenesis and determine treatment and long-term outcomes in this rare and heterogeneous disease.